Distinct Echocardiographic Phenotypes in Primary vs. Secondary Iron Overload Cardiomyopathy: A Pilot Study on

Luis Andrés Vega-Quesada1, Zuilma Yurith Vásquez-Ortiz1, María Elena Soto-López2

  • 1Department of Echocardiography, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.

Insights

Secondary hemochromatosis patients have worse iron overload cardiomyopathy outcomes than primary hemochromatosis patients. Myocardial work indices may offer insights into iron burden and cardiac toxicity beyond traditional measures.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomarkers

Background:

  • Iron overload cardiomyopathy (IOC) is a significant complication of hemochromatosis, potentially missed by conventional echocardiography.
  • Comparative analysis of myocardial work (MW) indices in primary (PH) versus secondary hemochromatosis (SH) is limited.

Purpose of the Study:

  • To compare echocardiographic phenotypes and myocardial work indices in PH and SH patients.
  • To investigate associations between iron burden and cardiac function using MW indices.

Main Methods:

  • Retrospective cross-sectional study of 34 hemochromatosis patients (16 PH, 18 SH).
  • Echocardiography with speckle-tracking for LV global longitudinal strain (GLS) and non-invasive MW indices (GWI, GCW, GWW, GWE).
  • Phenotypic classification: Normal, Dilated, Restrictive, RVPH.

Main Results:

  • SH patients had higher iron burden, neurohormonal activation, and mortality (33% vs 0%) despite similar LVEF and GLS.
  • PH patients predominantly had Normal phenotypes (81%), while SH patients showed more advanced phenotypes (RVPH, Dilated).
  • Global work index (GWI) correlated inversely with ferritin, especially in SH patients. Global wasted work (GWW) was higher in advanced phenotypes.

Conclusions:

  • Primary and secondary hemochromatosis present distinct IOC phenotypes, with SH associated with worse outcomes and advanced cardiac remodeling.
  • Myocardial work indices show potential as complementary tools to assess iron burden and cardiac toxicity, complementing LVEF and GLS.
  • These findings require validation in larger prospective studies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...